companies astrazeneca-plc 
The Crime Report
AUGUST 12, 2021
and partner BioNTech SE, Johnson & Johnson as well as AstraZeneca PLC. Countries whose national, regional or tribal governments were approached include the Netherlands, Latvia, France, Israel, the Czech Republic, Austria, Argentina, Colombia, Brazil, Canada and Spain. Some of the governments were offered vaccines from Pfizer Inc.
Law 360
JULY 3, 2024
AstraZeneca PLC and a U.K. affiliate beat late Tuesday a Delaware Court of Chancery stockholder suit accusing the company of orchestrating an underpriced, $3 billion sale of clinical stage biopharmaceutical venture Viela Bio Inc. in order to clear the way for AstraZeneca's purchase of a larger competitor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Law 360
NOVEMBER 1, 2024
A stockholder representative for former shareholders of biopharmaceutical company Syntimmune has proposed up to $755 million in additional damages after a Delaware vice chancellor found that an AstraZeneca PLC unit failed to reasonably pursue drug development milestones after acquiring Syntimmune in 2018.
Law 360
SEPTEMBER 6, 2024
The Delaware Chancery Court on Thursday awarded $130 million to former shareholders of biopharmaceutical company Syntimmune in their breach of contract fight against AstraZeneca PLC unit Alexion Pharmaceuticals Inc.,
Law 360
OCTOBER 21, 2021
Delaware's Supreme Court on Thursday upheld without elaboration a Chancery Court finding that cleared AstraZeneca PLC of liability for $275 million in post-merger cancer drug development "milestone" payments to investors in biopharmaceutical company Amplimmune LLC.
Expert insights. Personalized for you.
98 
Let's personalize your content